Liraglutide treatment ameliorates IL-1-induced ROS production in cardiomyocytes, protects against IL-1-induced loss of mitochondrial membrane potential and decreased ATP generation, and counteracts IL-1-induced alterations in AMPK and acetyl-CoA carboxylase phosphorylation as well as the reduction of peroxisome proliferator-activated receptor coactivator-1 (PGC-1), which is a key regulator whose downregulation leads to cardiac mitochondrial dysfunction (168)
[1] [2] This is characteristic of the incretin class as a whole and appears related to the pace of dose escalation
Cadmium-induced oxidative damage in mustard [Brassica juncea(L.)Czern.& Coss
GLP-1 receptor agonists are medications that affect pathways involved in blood sugar, appetite, and digestion
In the SURPASS clinical trials for type 2 diabetes, nausea occurred in 1222% of patients, diarrhea in 1216%, and vomiting in 59%, with incidence varying by dose
Apply cold compresses gently and avoid touching the area